Eisai
4523.T
#1922
Rank
HK$65.40 B
Marketcap
HK$232.04
Share price
-0.56%
Change (1 day)
-42.17%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Market capitalization of Eisai (4523.T)

Market cap: HK$65.40 Billion

As of November 2024 Eisai has a market cap of HK$65.40 Billion. This makes Eisai the world's 1922th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Eisai from 2000 to 2024

End of year Market Cap

Year Marketcap Change
2024HK$65.40 B-41.61%
2023HK$112.01 B-23.2%
2022HK$145.84 B14.95%
2021HK$126.87 B-20.11%
2020HK$158.82 B-5.53%
2019HK$168.12 B-2.68%
2018HK$172.74 B35.97%
2017HK$127.05 B-0.69%
2016HK$127.92 B-13.67%
2015HK$148.18 B71.24%
2014HK$86.53 B0.8%
2013HK$85.85 B-7.2%
2012HK$92.51 B1.92%
2011HK$90.77 B13.45%
2010HK$80.01 B-1.61%
2009HK$81.31 B-13.07%
2008HK$93.53 B2.65%
2007HK$91.12 B-25.44%
2006HK$122.21 B31.46%
2005HK$92.96 B26.45%
2004HK$73.52 B18.86%
2003HK$61.85 B21.1%
2002HK$51.07 B-10.76%
2001HK$57.23 B-29.22%
2000HK$80.85 B